comparemela.com

Latest Breaking News On - Negma group - Page 5 : comparemela.com

Mendus announces request for conversion of convertible bonds by Negma Group

Mendus AB , a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced that Negma Group has by notice to Mendus requested the conversion of convertible bonds. | March 28, 2023

Erik mantingCorey davisMario brkuljValency communicationsSwedish companies registration officeNegma groupLifesci advisorsSci advisorsMendus ab publ stock exchangePress releaseOnvertible immu se0005003654

Mendus announces request for conversion of convertible bonds by Negma Group

Mendus AB , a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced that Negma Group has by notice to Mendus requested the conversion of convertible bonds. | March 27, 2023

Erik mantingCorey davisMario brkuljSwedish companies registration officeValency communicationsLifesci advisorsNegma groupSci advisorsMendus ab publ stock exchangePress releaseOnvertible immu se0005003654

Mendus announces request for conversion of convertible bonds by Negma Group

Mendus AB , a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced that Negma Group has by notice to Mendus requested the conversion of convertible bonds. | March 23, 2023

Corey davisErik mantingMario brkuljSwedish companies registration officeValency communicationsNegma groupLifesci advisorsSci advisorsMendus ab publ stock exchangePress releaseOnvertible immu se0005003654

Mendus AB: Mendus secures second shareholder loan from Van Herk Investments and reduces the number of outstanding convertible bonds with Negma Group

07.03.2023 - Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced that the Company has closed a second loan under the terms of the commitment from its largest shareholder Van Herk .

Mario brkuljErik mantingCorey davisLotta fermLifesci advisorsNegma groupValency communicationsChief financial officerVan herk investmentsAbuse regulationSci advisorsMendus ab

Oxurion NV: Oxurion Receives Transparency Notification from Negma Group

Oxurion Receives Transparency Notification from Negma Group Leuven, BELGIUM, Boston, MA, US - March 2, 2023 - 7.00 PM CET Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing

United statesRegion flamandeDennis riedlMaryt conwayTom graneyMichael dillenChristopher brinzeyConway communicationsCompany annualNegma groupNegma group ltdOxurion receives transparency notificationEuronext brusselsBelgian transparency

vimarsana © 2020. All Rights Reserved.